A Multicenter Phase I/II Study of the BCNU Implant (Gliadel<sup>®</sup> Wafer) for Japanese Patients with Malignant Gliomas-Reference-Cited by-同舟云学术

A Multicenter Phase I/II Study of the BCNU Implant (Gliadel^® Wafer) for Japanese Patients with Malignant Gliomas

Published:2014 Issue:4 Volume:54 Page:290-301
ISSN:0470-8105
Container-title:Neurologia medico-chirurgica
language:en
Short-container-title:Neurol. Med. Chir.(Tokyo)

Author:

AOKI Tomokazu¹,NISHIKAWA Ryo²,SUGIYAMA Kazuhiko³,NONOGUCHI Naosuke⁴,KAWABATA Noriyuki⁴,MISHIMA Kazuhiko²,ADACHI Jun-ichi²,KURISU Kaoru³,YAMASAKI Fumiyuki³,TOMINAGA Teiji⁵,KUMABE Toshihiro⁵⁶,UEKI Keisuke⁷,HIGUCHI Fumi⁷,YAMAMOTO Tetsuya⁸,ISHIKAWA Eiichi⁸,TAKESHIMA Hideo⁹,YAMASHITA Shinji⁹,ARITA Kazunori¹⁰,HIRANO Hirofumi¹⁰,YAMADA Shinobu¹¹,MATSUTANI Masao²,

Affiliation:

1. Department of Neurosurgery, National Hospital Organization Kyoto Medical Center

2. Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center

3. Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University

4. Department of Neurosurgery, Kitano Hospital

5. Department of Neurosurgery, Tohoku University Graduate School of Medicine

6. Department of Neurosurgery, Kitasato University School of Medicine (current affiliation)

7. Department of Neurosurgery, Dokkyo Medical University Hospital

8. Department of Neurosurgery, Faculty of Medicine, University of Tsukuba

9. Department of Neurosurgery, Faculty of Medicine, University of Miyazaki Hospital

10. Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University

11. Nobelpharma Co., Ltd.

Publisher

Japan Neurosurgical Society

Subject

Neurology (clinical),Surgery

Link

https://www.jstage.jst.go.jp/article/nmc/54/4/54_oa2013-0112/_pdf

Reference14 articles.

1. 1) Committee of Brain Tumor Registry of Japan: Report of brain tumor registry of Japan (1984–2000), 12th ed. Neurol Med Chir (Tokyo) 49(Suppl): S1–96, 2009

2. 2) Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345: 1008–1012, 1995

3. 3) Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T: Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41: 44–48; discussion 48–49, 1997

4. 4) Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5: 79–88, 2003

5. 5) National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology-v.1, 2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort;Journal of Neuro-Oncology;2024-05-23

2. A Leap Beyond Traditional Methods: A Case Report on the Horizontal Loop Distal Shoe;Cureus;2024-05-06

3. Unmanageable Cerebrospinal Fluid Leakage With Eosinophilic Meningitis in a Gliadel Wafer Implant Patient;Cureus;2024-05-06

4. Pharmaceutical polymers in conventional dosage forms;Polymers for Pharmaceutical and Biomedical Applications;2024

5. Residual pattern of the hyperintense area on T2-weighted magnetic resonance imaging after initial treatment predicts the pattern and location of recurrence in patients with newly diagnosed glioblastoma;2023-08-28